Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

Br J Cancer · 2004 · PMC2410221 · PMID 15026797

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Both the median FEV1 (66% predicted: range 47–87%) and K C0 (84% predicted; range 68–100%) were lower than those of the whole cohort, but the differences did not reach statistical significance.

also in 111,027 other papers

a nonsignificant trendno p-value reported

When analysed by tumour type, there is a nonsignificant trend for improved prognosis for patients with seminoma.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.